Cotiviti Appoints Ric Sinclair as CEO
Ric Sinclair, Chief Executive Officer, Cotiviti | Effective March 16, 2026・ Photo Credit: Cotiviti
Corporate Business News Sponsored by Business Watch Global
SALT LAKE CITY, March 9, 2026 (VSNewsNetwork.com) — Healthcare technology company Cotiviti has announced the appointment of Ric Sinclair as Chief Executive Officer and member of the Board of Directors, effective March 16, 2026. Dr. Emad Rizk will transition from his roles as CEO, President, and Chairman to Senior Advisor to the Board of Directors and Executive Team.
Sinclair joins Cotiviti from Waystar, where he served as Chief Business Officer.
“I’m excited to join Cotiviti at a defining moment in its journey. With our exceptional team and solid foundation, we are uniquely positioned to shape the next era of healthcare innovation. My priority is to accelerate this transformation — unlocking efficiency, reducing complexity, and delivering measurable improvements across both medical and administrative challenges for all stakeholders in healthcare,” said Sinclair.
@VSNewsNetwork
•
@VSNewsNetwork •
Dr. Rizk led Cotiviti for ten years, during which the company expanded its capabilities and market presence through acquisitions, including Edifecs. In his duration, he oversaw the integration of Edifecs in partnership with Veritas and KKR, advancing the company’s technology platform and interoperability initiatives.
“Leading Cotiviti has been a privilege. I am thankful for the dedication of the senior leadership team and the commitment of our owner-employees. Together, we built a resilient foundation and cultivated a culture built on respect and excellence, all supported by collaboration and purpose. I am confident the organization is well positioned to continue delivering meaningful impact across the healthcare ecosystem. With Ric Sinclair’s appointment as CEO, I believe his expertise and vision make him exceptionally qualified to guide Cotiviti into the next chapter, focused on supporting a more efficient and effective healthcare system,” said Dr. Rizk.
“As a long-standing partner and investor in Cotiviti, we have witnessed the company’s remarkable journey firsthand. We are delighted to support Cotiviti’s next phase under Ric Sinclair’s leadership and remain confident in the team’s ability to drive continued success. We express our deepest gratitude to Dr. Rizk for his insightful leadership and steadfast commitment. Under his guidance, Cotiviti has evolved into a dynamic organization, achieved remarkable results for its clients, and fostered a collaborative workplace that will leave a lasting positive impact on Cotiviti’s future achievements,” said Ramzi Musallam, CEO and Managing Partner of Veritas.
“We are pleased to have Ric Sinclair join us in Cotiviti’s next chapter of growth. Ric has a strong track record of advancing technology platforms, and we believe his product vision, operational discipline, and growth orientation will position the company for continued success. We extend our sincerest appreciation to Dr. Rizk for his exemplary leadership and unwavering dedication, which have been instrumental in building Cotiviti’s robust foundation and shaping the organization’s legacy,” said Max Lin, Partner at KKR.
Cotiviti’s integrated technology platform leverages data analytics and artificial intelligence to support healthcare organizations in improving quality, reducing costs, and enhancing operational efficiency.
For more information, visit www.cotiviti.com.
Source: Cotiviti